UK Markets close in 7 hrs 52 mins
  • FTSE 100

    7,540.91
    +31.76 (+0.42%)
     
  • FTSE 250

    20,398.18
    +15.42 (+0.08%)
     
  • AIM

    934.50
    +0.39 (+0.04%)
     
  • GBP/EUR

    1.1858
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2031
    -0.0027 (-0.2250%)
     
  • BTC-GBP

    19,968.08
    -173.89 (-0.86%)
     
  • CMC Crypto 200

    569.50
    -21.26 (-3.60%)
     
  • S&P 500

    4,297.14
    +16.99 (+0.40%)
     
  • DOW

    33,912.44
    +151.39 (+0.45%)
     
  • CRUDE OIL

    88.79
    -0.62 (-0.69%)
     
  • GOLD FUTURES

    1,792.60
    -5.50 (-0.31%)
     
  • NIKKEI 225

    28,868.91
    -2.87 (-0.01%)
     
  • HANG SENG

    19,760.62
    -280.24 (-1.40%)
     
  • DAX

    13,862.58
    +45.97 (+0.33%)
     
  • CAC 40

    6,585.84
    +15.89 (+0.24%)
     

Orion Corporation: Managers’ transactions – Virve Laitinen

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Orion Oyj
Orion Oyj

ORION CORPORATION
MANAGERS’ TRANSACTIONS
5 August 2022 at 11.15 EEST              

Orion Corporation: Managers’ transactions – Virve Laitinen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions
____________________________________________

Person subject to the notification requirement
Name: Virve Laitinen
Position: Other senior manager

Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 18216/4/4
____________________________________________

Transaction date: 2022-08-04
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014377
Nature of the transaction: DISPOSAL

Transaction details
(1): Volume: 4000 Unit price: 47,00 EUR

Aggregated transactions
(1): Volume: 4000 Volume weighted average price: 47,00 EUR

Orion Corporation

Timo Lappalainen

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 

                                                

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting